About the Authors

Myriam Rai

Affiliation Laboratoire de Neurologie Expérimentale, Hôpital Erasme, Université Libre de Bruxelles (ULB), Brussels, Belgium

Elisabetta Soragni

Affiliation Department of Molecular Biology, The Scripps Research Institute, La Jolla, California, United States of America

Kai Jenssen

Current address: Merz Pharmaceutical GmbH, Frankfurt am Main, Germany

Affiliation Department of Molecular Biology, The Scripps Research Institute, La Jolla, California, United States of America

Ryan Burnett

Affiliation Department of Molecular Biology, The Scripps Research Institute, La Jolla, California, United States of America

David Herman

Affiliation Department of Molecular Biology, The Scripps Research Institute, La Jolla, California, United States of America

Giovanni Coppola

Affiliation Program in Neurogenetics, Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America

Daniel H. Geschwind

Affiliation Program in Neurogenetics, Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America

Joel M. Gottesfeld

Affiliation Department of Molecular Biology, The Scripps Research Institute, La Jolla, California, United States of America

Massimo Pandolfo

massimo.pandolfo@ulb.ac.be

Affiliation Laboratoire de Neurologie Expérimentale, Hôpital Erasme, Université Libre de Bruxelles (ULB), Brussels, Belgium

Competing Interests

MP and JMG are consultants for Repligen, Inc., that has licensed the described HDAC inhibitors for the Scripps Research Institute. The other authors have no competing interests.

Author Contributions

Conceived and designed the experiments: MP MR DG JG. Performed the experiments: MR GC ES KJ RB DH. Analyzed the data: MP MR GC DG JG. Contributed reagents/materials/analysis tools: ES KJ RB DH. Wrote the paper: MP MR DG JG.